FindTrial
Sign In

Clinical outcomes of microwave ablation combined with chemotherapy versus chemotherapy alone for pulmonary malignancies

Clinical outcomes of microwave ablation combined with chemotherapy versus chemotherapy alone for pulmonary malignancies

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025055
Enrollment
Unknown
Registered
2019-08-09
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung caner

Interventions

2:microwave therapy combined with chemotherapy
1:chemotherapy alone

Sponsors

Yunnan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) All patients were diagnosed with lung cancer; (2) Aged 20-50 years; (3) All patients were treated with standardized chemotherapy.

Exclusion criteria

Exclusion criteria: (1) Patients with diabetes, hyperlipidemia, cardiovascular and cerebrovascular diseases; (2) Patients with severe liver and kidney diseases and cancer; (3) Long-term alcoholics.

Design outcomes

Primary

MeasureTime frame
overall response;over all response;complication;—

Countries

China

Contacts

Public ContactZheng Chenhong

Yunnan Cancer Hospital

54290838@163.com+86 15210090091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026